アブストラクト
| Title | GLP-2アナログ製剤の長期投与経験 |
|---|---|
| Subtitle | 特集 小児領域におけるGLP-2アナログ製剤 (テデュグルチド) の応用 各論 : 各疾患に対する使用経験 |
| Authors | 安藤亮*, 工藤博典, 櫻井毅, 和田基 |
| Authors (kana) | |
| Organization | *東北大学大学院医学系研究科外科病態学講座小児外科学分野 |
| Journal | 小児外科 |
| Volume | 56 |
| Number | 4 |
| Page | 403-407 |
| Year/Month | 2024 / 4 |
| Article | 報告 |
| Publisher | 東京医学社 |
| Abstract | 「はじめに」腸管不全 (intestinal failure : IF) とは腸管機能の低下により生命の維持や成長に最低限必要な栄養, 水分, 電解質が腸管から吸収できず, 経静脈的な補給を要する病態と定義される. IFの原因として短腸症候群 (short bowel syndrome : SBS) や腸管運動機能障害, 難治性下痢などの腸管吸収機能障害による機能的腸管不全があげられる. SBSは北米小児消化器肝臓栄養学会では残存する小腸が正常の25%以下, もしくは60日以上の静脈栄養 (parenteral nutrition : PN) の必要な状態と定義している. 小児慢性特定疾患ではSBSは小腸の大量切除に伴う吸収不良の状態と定義され, 一般的に小腸の70〜80%を切除すると厳重な栄養管理を要する. |
| Practice | 臨床医学：外科系 |
| Keywords |
- 全文ダウンロード： 従量制、基本料金制の方共に1,023円(税込) です。
参考文献
- 1) Pironi L, Arends J, Baxter J, et al: ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults. Clin Nutr 34: 171-180, 2015
- 2) Gattini D, Roberts AJ, Wales PW, et al: Trends in Pediatric Intestinal Failure: A Multicenter, Multinational Study. J Pediatr 237: 16-23.e4, 2021
- 3) Merritt RJ, Cohran V, Raphael BP, et al: Intestinal Rehabilitation Programs in the Management of Pediatric Intestinal Failure and Short Bowel Syndrome. J Pediatr Gastroenterol Nutr 65: 588-596, 2017
- 4) 小児慢性疾患疾病情報センター: 短腸症 https://www.shouman.jp/disease/details/12_13_037/ (2024年1月31日アクセス)
- 5) 加治 建, 矢野圭輔, 杉田光士郎, 他: 短腸症候群の治療 =腸管順応促進ホルモン・ペプチド成長因子. 小児外科 54: 306-310, 2022
残りの12件を表示する
- 6) Schwartz LK, O'Keefe SJ, Fujioka K, et al: Long-Term Teduglutide for the Treatment of Patients With Intestinal Failure Associated With Short Bowel Syndrome. Clin Transl Gastroenterol 7: e142, 2017
- 7) Seidner DL, Fujioka K, Boullata JI, et al: Reduction of Parenteral Nutrition and Hydration Support and Safety With Long-Term Teduglutide Treatment in Patients With Short Bowel Syndrome -Associated Intestinal Failure: STEPS-3 Study. Nutr Clin Pract 33: 520-527, 2018
- 8) de Dreuille B, Nuzzo A, Bataille J, et al: Post-Marketing Use of Teduglutide in a Large Cohort of Adults with Short Bowel Syndrome-Associated Chronic Intestinal Failure: Evolution and Outcomes. Nutrients 15: 2448, 2023
- 9) Ramos Boluda E, Redecillas Ferreiro S, Manrique Moral O, et al: Experience With Teduglutide in Pediatric Short Bowel Syndrome: First Real-life Data. J Pediatr Gastroenterol Nutr 71: 734-739, 2020
- 10) Lambe C, Talbotec C, Kapel N, et al: Long-term treatment with teduglutide: a 48-week open-label single-center clinical trial in children with short bowel syndrome. Am J Clin Nutr 117: 1152-1163, 2023
- 11) Guz-Mark A, Hino B, Berkowitz D, et al: The Variable Response to Teduglutide in Pediatric Short Bowel Syndrome: A Single Country Real-Life Experience. J Pediatr Gastroenterol Nutr 75: 293-298, 2022
- 12) Compher C, Gilroy R, Pertkiewicz M, et al: Maintenance of parenteral nutrition volume reduction, without weight loss, after stopping teduglutide in a subset of patients with short bowel syndrome. JPEN J Parenter Enteral Nutr 35: 603-609, 2011
- 13) Zaczek Z, Jurczak-Kobus P, Panczyk M, et al: Changes in Parenteral Nutrition Requirements and BMI in Patients with Parenteral Nutrition-Dependent Short Bowel Syndrome after Stopping Teduglutide -9 Years of Follow-Up. Nutrients 14: 1634, 2022
- 14) Hill S, Carter BA, Cohran V, et al: Safety Findings in Pediatric Patients During Long-Term Treatment With Teduglutide for Short-Bowel Syndrome-Associated Intestinal Failure: Pooled Analysis of 4 Clinical Studies. JPEN J Parenter Enteral Nutr 45: 1456-1465, 2021
- 15) Salazar JA, Goldsmith JD, Jimenez L, et al: Gastric Foveolar Hyperplastic Polyps in 2 Children With Short Bowel Syndrome on Long-Term Teduglutide. JPGN Rep 13: e389, 2023
- 16) Kim DW, Kim E, Bertram K, et al: Long-term outcomes and adverse effects of teduglutide in patients with short bowel syndrome: Highlighting hyperamylasemia and hyperlipasemia. Am J Health Syst Pharm, 2023 doi:10.1093/ajhp/zxad274
- 17) Chen K, Joly F, Mu F, et al: Predictors and timing of response to teduglutide in patients with short bowel syndrome dependent on parenteral support. Clin Nutr ESPEN 43: 420?427, 2021
